Expression and function of the cholinergic system in immune cells

T Fujii, M Mashimo, Y Moriwaki, H Misawa… - Frontiers in …, 2017 - frontiersin.org
T and B cells express most cholinergic system components—eg, acetylcholine (ACh),
choline acetyltransferase (ChAT), acetylcholinesterase, and both muscarinic and nicotinic …

Multi-target design strategies for the improved treatment of Alzheimer's disease

P Zhang, S Xu, Z Zhu, J Xu - European journal of medicinal chemistry, 2019 - Elsevier
Alzheimer's disease (AD) is a multifactorial syndrome resulting in profound misery and
poses a substantial burden on human health, economy, and society throughout the world …

[PDF][PDF] Cholinesterases, a target of pharmacology and toxicology.

M Pohanka - Biomedical Papers of the Medical Faculty of …, 2011 - pdfs.semanticscholar.org
Background. Cholinesterases are a group of serine hydrolases that split the neurotransmitter
acetylcholine (ACh) and terminate its action. Of the two types, butyrylcholinesterase and …

Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus

G Mushtaq, NH Greig, JA Khan… - CNS & Neurological …, 2014 - ingentaconnect.com
Both Alzheimer's disease (AD) and Type 2 diabetes mellitus (T2DM) share the presence of
systemic and neuro-inflammation, enhanced production and accumulation of β-amyloid …

Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment

DL Eaton, RB Daroff, H Autrup, J Bridges… - Critical reviews in …, 2008 - Taylor & Francis
This review examines the large body of toxicological and epidemiological information on
human exposures to chlorpyrifos, with an emphasis on the controversial potential for …

[HTML][HTML] A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease

A Nordberg, C Ballard, R Bullock… - The primary care …, 2013 - psychiatrist.com
Objective: To examine the role of butyrylcholinesterase (BuChE) in cholinergic signaling and
neurologic conditions, such as Alzheimer's disease (AD). The rationale for inhibiting …

Cholinesterase inhibitors: new roles and therapeutic alternatives

E Giacobini - Pharmacological research, 2004 - Elsevier
An important aspect of brain cholinesterase function is related to enzymatic differences. The
brain of mammals contains two major forms of cholinesterases: acetylcholinesterase (AChE) …

Butyrylcholinesterase: an important new target in Alzheimer's disease therapy

NH Greig, DK Lahiri, K Sambamurti - International psychogeriatrics, 2002 - cambridge.org
Acetylcholinesterase (AChE) predominates in the healthy brain, with butyrylcholinesterase
(BuChE) considered to play a minor role in regulating brain acetylcholine (ACh) levels …

The multifactorial nature of Alzheimer's disease for developing potential therapeutics

M Carmo Carreiras, E Mendes… - Current topics in …, 2013 - ingentaconnect.com
Alzheimerβs disease (AD) is a multifactorial neurodegenerative disorder with several target
proteins contributing to its aetiology. Pathological, genetic, biochemical, and modeling …

Current pharmacotherapy for Alzheimer's disease

A Lleo, SM Greenberg, JH Growdon - Annu. Rev. Med., 2006 - annualreviews.org
Alzheimer's disease (AD) is an age-related neurodegenerative disease that affects
approximately 4.5 million people in the United States. The mainstays of current …